Andrew A. Dahl, MD, is a board-certified ophthalmologist. Dr. Dahl's educational background includes a BA with Honors and Distinction from Wesleyan University, Middletown, CT, and an MD from Cornell University, where he was selected for Alpha Omega Alpha, the national medical honor society. He had an internal medical internship at the New York Hospital/Cornell Medical Center.
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
The prognosis depends on the underlying cause. Most episodes resolve spontaneously, with return of vision in two weeks to three months. About 90% of people with optic neuritis will recover most of their vision within six months of onset. However, about 14% will have a recurrence of optic neuritis in the affected eye, and 12% will develop optic neuritis in the other eye within 10 years. If the
patient has one or more abnormal lesions on the MRI, the risk of MS within 15 years is 72%.
Where can I find more information on optic neuritis?
American Academy of Ophthalmology
Medically reviewed by John P. Keenan, MD; Board Certified Opthamology